Insecticides

590.85
-16.95
(-2.79%)
Market Cap
1,719.25 Cr
EPS
34.59
PE Ratio
13.27
Dividend Yield
0.49 %
Industry
Chemicals
52 Week High
1,084.25
52 Week Low
476.00
PB Ratio
1.61
Debt to Equity
0.13
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+100.00 %
+100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
3,428.20
#1 52,012.01
31.16
7,873.50
#1 18.38
#1 1,682
-16.92
55.43
636.25
47,759.53
-
#1 43,581.00
-19.37
-1,878
153.08
51.91
559.35
27,919.72
51.24
2,939.60
-17.33
370
59.78
71.44
4,909.60
22,064.77
40.73
5,184.20
-0.37
741
-63.27
52.21
1,293.85
5,832.46
#1 21.06
1,793.50
2.78
239
21.15
52.14
571.55
5,156.55
22.33
3,222.80
-21.11
32
#1 576.09
51.29
10,578.55
4,395.67
24.12
1,065.50
-15.01
96
164.71
54.26
214.28
4,167.08
31.33
2,631.40
6.54
164
-274.07
43.81
278.05
3,605.45
167.63
410.30
-18.49
18
9.09
36.05
101.78
2,029.89
-
1,787.30
-15.91
-59
-127.67
66.87
Growth Rate
Revenue Growth
9.61 %
Net Income Growth
62.03 %
Cash Flow Change
1,827.85 %
ROE
46.80 %
ROCE
30.35 %
EBITDA Margin (Avg.)
27.53 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
319
459
217
200
360
505
264
238
411
461
300
258
470
444
315
280
561
583
357
302
644
696
359
277
659
629
358
Expenses
263
389
184
170
295
431
240
241
370
398
284
227
415
380
295
244
502
514
333
331
594
614
332
264
585
538
327
EBITDA
56
70
33
30
64
74
24
-3
41
63
16
31
55
64
20
36
59
69
24
-28
50
82
27
13
74
91
31
Operating Profit %
17 %
15 %
15 %
15 %
18 %
14 %
9 %
-1 %
10 %
13 %
5 %
11 %
11 %
14 %
6 %
12 %
10 %
12 %
7 %
-9 %
7 %
12 %
7 %
3 %
11 %
14 %
9 %
Depreciation
5
5
5
5
6
6
6
6
6
6
6
6
6
6
7
7
7
6
6
7
7
7
7
8
7
7
8
Interest
3
2
4
6
7
6
6
5
2
1
2
1
2
2
2
1
1
3
5
5
3
3
3
2
2
2
1
Profit Before Tax
48
62
24
19
52
62
12
-15
32
55
8
24
47
56
11
28
51
60
12
-39
40
72
17
4
65
82
22
Tax
14
19
7
-10
16
13
3
-7
8
14
2
2
12
14
3
6
13
15
3
-10
11
19
5
-4
16
21
5
Net Profit
34
43
17
29
36
49
9
-7
24
42
6
22
35
42
8
22
38
45
9
-29
29
53
12
8
49
62
17
EPS in ₹
16.52
20.80
8.25
13.85
17.47
23.72
4.30
-3.44
11.79
20.13
2.97
10.54
17.37
21.22
4.18
7.55
19.41
15.15
3.16
-9.90
9.85
17.95
4.16
2.62
16.56
20.78
5.96

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
920
936
978
1,000
1,356
1,294
1,426
1,396
1,696
1,714
Fixed Assets
210
199
185
232
240
239
239
253
263
284
Current Assets
662
675
715
720
1,062
978
1,086
1,003
1,232
1,248
Capital Work in Progress
38
51
58
17
19
39
59
91
123
142
Investments
0
0
11
17
13
12
14
16
17
20
Other Assets
673
687
725
735
1,084
1,005
1,115
1,037
1,294
1,268
Total Liabilities
920
936
978
1,000
1,356
1,294
1,426
1,396
1,696
1,714
Current Liabilities
556
476
489
425
674
539
585
508
760
656
Non Current Liabilities
74
52
25
28
20
23
21
19
19
44
Total Equity
291
409
465
548
662
732
820
870
918
1,014
Reserve & Surplus
278
388
444
527
641
711
800
850
889
984
Share Capital
13
21
21
21
21
21
21
20
30
30

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-4
4
-0
13
-11
59
-61
30
-17
43
Investing Activities
-34
-19
-14
-26
-49
-24
-113
9
-86
-43
Operating Activities
-6
86
4
182
-133
242
155
135
-11
184
Financing Activities
36
-64
9
-143
172
-159
-104
-115
80
-98

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
68.89 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.16 %
72.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.19 %
4.42 %
4.32 %
4.36 %
5.43 %
5.13 %
DIIs
9.17 %
9.56 %
9.53 %
8.79 %
8.79 %
10.85 %
10.96 %
10.96 %
10.79 %
10.55 %
9.41 %
9.13 %
9.16 %
9.09 %
9.08 %
9.24 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.23 %
9.87 %
9.64 %
9.61 %
8.75 %
7.93 %
7.72 %
7.31 %
7.24 %
7.87 %
9.40 %
10.39 %
10.59 %
11.10 %
10.14 %
10.31 %
Others
10.71 %
8.41 %
8.67 %
9.44 %
10.31 %
9.05 %
9.17 %
9.58 %
9.82 %
9.42 %
3.85 %
3.90 %
3.78 %
3.29 %
3.20 %
3.02 %
No of Share Holders
0
16,328
15,883
15,977
15,999
15,401
14,233
20,223
16,355
18,012
18,868
18,232
19,252
19,474
22,484
22,849

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2 2 2 4 2 3 3 3 0.00
Dividend Yield (%) 0.00 0.44 0.45 0.96 1.27 0.49 0.63 0.62 0.51 0.00

Corporate Action

Announcements

Board Meeting Intimation for Board Meeting Intimation6 days ago
Closure of Trading Window6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 11, 2025
Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 27, 2025
Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2025
Integrated Filing (Financial)Feb 10, 2025
Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On December 30 2024.Feb 10, 2025
Board Meeting Outcome for Outcome Of Board MeetingFeb 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 06, 2025
Announcement Under Regulation 30 (LODR)- (Product Launch)Jan 06, 2025
Board Meeting Intimation for Prior Intimation Of Board MeetingDec 27, 2024
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 23, 2024
Announcement Under Regulation 30 (LODR)- (Product Launch) Dec 23, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 17, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 03, 2024
Intimation Of Receipt Of PATENT (FUNGICIDAL COMPOSITIONS AND METHODS RELATED THERETO)Nov 22, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 15, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2024
Intimation Of Comments Made By The Board Of Directors.Nov 11, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 11, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2024
Announcement under Regulation 30 (LODR)-AcquisitionNov 11, 2024
Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On September 30, 2024.Nov 11, 2024
Board Meeting Outcome for Outcome Of Board MeetingNov 11, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 11, 2024
Announcement under Regulation 30 (LODR)-Closure of Buy BackOct 10, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 01, 2024
Closure of Trading WindowSep 27, 2024
Board Meeting Intimation for Prior Intimation Of Board MeetingSep 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 17, 2024
Draft Of The Offer Opening Advertisement Cum Corrigendum To The Letter Of Offer Pertaining To The Ongoing Buyback.Sep 16, 2024
Letter Of Offer Pertaining To The Buyback Of The Equity Shares By The CompanySep 13, 2024

Technical Indicators

RSI(14)
Neutral
46.31
ATR(14)
Volatile
21.89
STOCH(9,6)
Neutral
55.97
STOCH RSI(14)
Neutral
30.46
MACD(12,26)
Bullish
1.53
ADX(14)
Weak Trend
17.20
UO(9)
Bearish
38.88
ROC(12)
Uptrend And Accelerating
1.51
WillR(14)
Neutral
-77.22